Algorithm Sciences, a Laidlaw Venture Partners Portfolio Company, Announces Board Appointments
October 04, 2021 09:00 ET
|
Laidlaw Venture Partners
NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the appointment of Anthony Zook and Gary...
PD Theranostics, Inc., a Laidlaw Venture Partners Portfolio Company, Executes Term Sheet With Massachusetts General Hospital
September 30, 2021 10:37 ET
|
Laidlaw Venture Partners
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced that its portfolio company, PD...
Algorithm Sciences, a Laidlaw Venture Partners Portfolio Company, Announces Key Management Appointments
September 15, 2021 10:17 ET
|
Laidlaw Venture Partners
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced key management appointments for its...
Laidlaw Venture Partners Portfolio Company Algorithm Sciences, Inc. Closes $5.0 Million Series B Financing Round
April 20, 2021 08:15 ET
|
Laidlaw Venture Partners
NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $5.0 million...
UPDATE – Laidlaw Venture Partners Portfolio Company AerWave Medical, Inc. Closes $4 Million Series A Financing Round
February 24, 2021 13:33 ET
|
Laidlaw Venture Partners
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $4 million...
Laidlaw Venture Partners Portfolio Company AerWave Medical, Inc. Closes $4 Million Series A Financing Round
February 24, 2021 11:31 ET
|
Laidlaw Venture Partners
NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the successful closing of a $4 million...
Laidlaw Venture Partners Portfolio Company Voltron Therapeutics Enters into Strategic Development Agreement With Translational Drug Development (TD2), a Precision Oncology Contract Research Organization (CRO)
November 23, 2020 08:00 ET
|
Laidlaw Venture Partners
NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced a strategic development agreement with...
Laidlaw Venture Partners Continues Strategic Growth with the Addition of Zachary Shriver, Ph.D. and George Steinfels, Ph.D., MBA as Strategic Advisors for Key Operational Activities
October 27, 2020 08:30 ET
|
Laidlaw Venture Partners
NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Zachary Shriver, Ph.D. and...
Laidlaw Venture Partners Continues Strategic Growth with Addition of Paul Korner, MD, MBA and Tony N. Hodges MD FCCP FACP, to its Investment and Operations Committee
October 20, 2020 08:30 ET
|
Laidlaw Venture Partners
NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of addition of Paul Korner, MD,...
Laidlaw Venture Partners Continues Strategic Growth with Addition of Mr. Anthony Zook to its Investment and Operations Committee
September 21, 2020 08:30 ET
|
Laidlaw Venture Partners
NEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Mr. Anthony (‘Tony’) Zook...